ISSN: 0114-5916

Journal Home

Journal Guideline

Drug Safety Q1 Unclaimed

Adis International Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drug Safety is a journal indexed in SJR in Pharmacology and Toxicology with an H index of 140. It has a price of 3290 €. It has an SJR impact factor of 1,204 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,204.

Drug Safety focuses its scope in these topics and keywords: drug, adverse, safety, surveillance, events, media, medicines, social, reactions, current, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q1) Pharmacology (medical) (Q1) Pharmacology (medical) (Q1) Toxicology (Q1)

Price

3290 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,204

SJR Impact factor

140

H Index

108

Total Docs (Last Year)

359

Total Docs (3 years)

4530

Total Refs

1291

Total Cites (3 years)

313

Citable Docs (3 years)

3.33

Cites/Doc (2 years)

41.94

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Journal for ImmunoTherapy of Cancer Q1

Compare this journals

Aims and Scope

Best articles by citations

Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950-2012

Long-Term Treatment with Atypical Antipsychotics and the Risk of Weight Gain

ISoP Fellowships: Recognising Contributions to the Goals of ISoP

Detecting Medication Errors in the New Zealand Pharmacovigilance Database

Comment on: "Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries"

Memantine for the Treatment of Alzheimer???s Disease

Safety of Agents Used to Prevent Mother-to-Child Transmission of HIV

Therapeutic Risk Management of Medicines

Lipodystrophy Syndrome in HIV Infection

Comment on: "Pharmacovigilance in the Middle East"

Comment on: "Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance"

Prevention and Management of Extravasation of Cytotoxic Drugs

SHOW MORE ARTICLES

Drug Safety Issues in Pregnancy Following Transplantation and Immunosuppression

Distinguishing Hazards and Harms, Adverse Drug Effects and Adverse Drug Reactions

Authors' Reply to Ahmad SR: "Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries"

A Comparison of the Empirical Performance of Methods for a Risk Identification System

Comment on: Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals Analysis of Trends in Dispensing Patterns in The Netherlands from 1998 to 2008

Carbapenems in Serious Infections

A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International Database

Authors' Reply to Harpaz et al. Comment on: "Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance"

Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System

Clinical Relevance and Predictive Value of Damage Biomarkers of Drug-Induced Kidney Injury

Adverse Drug Reaction Reporting in the UK

Labelling and ???Dear Doctor??? Letters